TABLE 1.
The result of MIC by using VITEK-2.
| Category | Antimicrobial agent | MIC (mg/L)/Antimicrobial susceptibility | ||||
|
|
||||||
| EC600 | RB20432 | RB20432-mcr-1-EC600 | DB20D28 | DB20D28-mcr-1-EC600 | ||
| Penicillin | Ampicillin | 8/S | ≥256/R | ≥256/R | ≥256/R | ≥256/R |
| Amoxicillin | ≤4/S | ≥256/R | ≥256/R | ≥256/R | ≥256/R | |
| β-lactam | Ceftazidime | ≤4/S | ≤4/S | ≤4/S | ≤4/S | ≤4/S |
| Imipenem | ≤1/S | ≥16/R | ≤1/S | ≤1/S | ≤1/S | |
| Colistin | Polymyxin B | ≤0.5/ S | ≥8/R | ≥8/R | 4/I | ≥8/R |
| Tetracycline | Tetracycline | 4/S | ≥128/R | ≥128/R | ≥128/R | ≥128/R |
| Aminoglycosides | Kanamycin | 8/S | ≥128/R | 32/I | ≥64/R | ≥64/R |
| Azithromycin | 8/S | ≥128/R | ≥64/R | ≤4/S | ≤4/S | |
| Gentamicin | ≤1/S | ≥16/R | 8/I | ≤1/S | ≤1/S | |
| Quinolines | Ciprofloxacin | ≤0.25/S | ≥4/R | ≥4/R | ≤0.25/S | ≤0.25/S |
| Sulfonamides | Sulfamethoxazole | ≤20/S | ≥320/R | ≥320/R | ≥320/R | ≥320/R |
S, susceptible; R, resistant; I, intermediate.